Increasing burden of viral bronchiolitis in the pediatric intensive care unit; an observational study

Rosalie S Linssen1, Anne C Teirlinck2, Michiel van Boven2

  • 1Pediatric Intensive Care Unit, Emma Children's Hospital, Amsterdam University Medical Centers, location AMC, Amsterdam, the Netherlands.

Insights

Pediatric intensive care unit (PICU) admissions for viral bronchiolitis have increased significantly over the past two decades. This growing burden necessitates international attention for resource planning.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Epidemiology

Background:

  • Viral bronchiolitis is a leading cause of pediatric intensive care unit (PICU) admissions.
  • Understanding trends in bronchiolitis-associated PICU admissions is crucial for effective healthcare resource and capacity planning.

Purpose of the Study:

  • To investigate the trends in PICU admissions for viral bronchiolitis across European sites from 2000 to 2019.
  • To analyze population-based admission rates and identify factors associated with severe disease.

Main Methods:

  • Retrospective study of 15,606 PICU admissions for bronchiolitis across six European sites.
  • Inclusion of national registries for population-based estimates.
  • Data collection on risk factors and mechanical ventilation use.

Main Results:

  • A consistent increase in the annual number and rate of PICU admissions for bronchiolitis was observed over the two-decade study period.
  • Population-based estimates per 100,000 children also showed an upward trend.
  • The proportion of high-risk patients remained stable, suggesting an overall increase in bronchiolitis cases requiring intensive care.

Conclusions:

  • The increasing international burden of bronchiolitis on PICUs is a significant concern.
  • Further international research and attention are warranted to address this growing public health issue.
  • Findings highlight the need for proactive strategies in pediatric critical care planning.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
547
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
417
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
446
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
247
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.7K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
534